Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and ...

A high-level overview of Rigel Pharmaceuticals, Inc. (RIGL) stock. View (RIGL) real-time stock price, chart, news, analysis, analyst reviews and more.

SiriusXM to Present at the J.P. Morgan 53rd Annual Global Technology, Media, and Communications Conference PR Newswire May 5, 2025, 1:30:00 PM ...

After losing Roche as a partner, Blueprint Medicines has sold US commercial rights to RET inhibitor Gavreto to Rigel Pharma in a deal worth up to $117.5 million.

On SiriusXM's 'Page Six Radio', hosts Danny Murphy, Evan Real and Ian Mohr break down the latest in entertainment and celebrity news. Listen daily from 8am-10am on SiriusXM Stars, Channel 109.

Review Article Published: March 2007 Therapy Insight: diabetes and drug-eluting stents Victor Legrand Nature Clinical Practice Cardiovascular Medicine 4, 143–150 (2007) Cite this article ...

Amassing 14 kids with four women, including conservative author Ashley St. Clair, Elon Musk appears to be building his own universe. We're exploring the truth about the mothers of his children.

Nasdaq Listed Alerts Market: Open SiriusXM Holdings Inc. Common Stock (SIRI) Bid: $21.46 X 31 Ask: $21.48 X 47 Volume: 1,203,464 ...